ALDOAP2: A Potential Drug Target and Biomarker (G228)

Target Name: ALDOAP2

NCBI ID: G228

ALDOAP2

Other Name(s): ALDOA pseudogene 2 | Aldolase A, fructose-bisphosphate pseudogene 2

ALDOAP2: A Potential Drug Target and Biomarker

Introduction

ALDOA pseudogene 2 (ALDOAP2) is a gene that has been identified in various organisms, including humans. It is a member of the ALDOA gene family, which encodes for the amino acid alkaline phosphatase (AP) gene. ALDOA pseudogene 2 has been shown to play a crucial role in the regulation of cellular processes, including cell signaling, DNA replication, and metabolism.

The discovery of ALDOAP2 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. In this article, we will explore the biology of ALDOAP2, its potential drug target status, and its potential as a biomarker for disease diagnosis and monitoring.

Biography of ALDOAP2

ALDOA pseudogene 2 is a single-copy gene that is located on chromosome 16 (16p13.1). It is a 194-basin pair gene that encodes for a protein with 259 amino acid residues (1.9 kilodalton). The protein encoded by ALDOAP2 is a member of the AP family, which includes several other genes that are involved in cellular signaling and metabolism.

Expression of ALDOAP2

ALDOAP2 is expressed in most tissues and cells of the body, including the brain, heart, liver, and muscle. It is highly expressed in the liver, with lower levels found in the heart, muscle, and brain. The expression of ALDOAP2 is regulated by various factors, including DNA replication, cell signaling, and metabolism.

Drug Target Status

The potential drug target status of ALDOAP2 is due to its involvement in cellular signaling and metabolism. Several studies have shown that ALDOAP2 is involved in the regulation of DNA replication, cell signaling, and metabolism (4,5). Additionally, ALDOAP2 has been shown to play a role in the regulation of cellular apoptosis. These properties make ALDOAP2 an attractive drug target for the development of new treatments for various diseases.

Potential Biomarkers

The potential use of ALDOAP2 as a biomarker for disease diagnosis and monitoring has significant implications. ALDOAP2 is expressed in most tissues and cells of the body, making it a potential candidate for use as a biomarker for a wide range of diseases.

One potential use of ALDOAP2 as a biomarker is its involvement in the regulation of DNA replication. diseases that affect DNA replication, such as cancer, have been shown to be associated with increased levels of ALDOAP2. Additionally, ALDOAP2 has been shown to play a role in the regulation of cell signaling and metabolism, which may be involved in the development and progression of many diseases.

In conclusion, the biology and potential uses of ALDOAP2 make it an attractive candidate for further study as a drug target and biomarker. Further research is needed to fully understand the role of ALDOAP2 in cellular signaling and metabolism, and to determine its potential as a treatment for various diseases.

Protein Name: ALDOA Pseudogene 2

The "ALDOAP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALDOAP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets